Previous Article | Next Article ![]()
Infection and Immunity, September 1998, p. 4496-4498, Vol. 66, No. 9
Division of Geographic Medicine and
Infectious Diseases and Tupper Research Institute,
Received 3 April 1998/Returned for modification 15 May
1998/Accepted 2 June 1998
To facilitate the study of intestinal transmission of the Shiga
toxin 1 (Stx1)-converting phage H-19B, Tn10d-bla
mutagenesis of an Escherichia coli H-19B lysogen was
undertaken. Two mutants containing insertions in the gene encoding the
A subunit of Stx1 were isolated. The resultant ampicillin-resistant
E. coli strains lysogenic for these phages produced
infectious H-19B particles but not active toxin. These lysogens were
capable of transducing an E. coli recipient strain in the
murine gastrointestinal tract, thereby demonstrating that lysogens of
Shiga toxin-converting phages give rise to infectious virions within
the host gastrointestinal tract.
Bacteriophages have played a
critical role in the evolution of many bacterial pathogens (reviewed in
references 3 and 6). Integrating
(temperate) phages often alter the properties of the host bacterial
cell upon establishment of lysogeny, a process known as phage
conversion. The toxins of a number of both gram-negative and
gram-positive pathogens have been found to be encoded in the genomes of
temperate bacteriophages. The presence of genes encoding virulence
factors in phage genomes provides a means for the dissemination of
these genes; however, the sites and conditions which favor bacteriophage conversion have not been studied.
The bacteriophage-encoded Shiga toxins (Stxs) are believed to play an
important role in the pathogenesis of hemorrhagic colitis, hemolytic-uremic syndrome, and thrombotic thrombocytopenic purpura that
may result from human infection with lysogenic Escherichia coli (8). Stxs are A-B-type toxins which bind to the
host glycolipid Gb3 (11). The enzymatically active A subunit
of Stx acts as an rRNA N-glycosidase on the eukaryotic 60S
ribosomal subunit and thereby inhibits protein synthesis
(7). Stx1 and Stx2 are the two principal Stxs found in
E. coli. Williams Smith and Linggood originally reported in
1971 that lysates of H19B, an E. coli O26:H11 strain
isolated from an outbreak of infantile diarrhea, could transfer
enterotoxinogenicity to E. coli K-12 in vitro
(21). This phage, known as H-19B, was subsequently shown to
encode Stx1 and to have DNA sequence homology to phage Construction of H-19B derivatives which encode ampicillin
resistance.
An antibiotic resistance marker was introduced into
the genome of the Stx1-encoding phage H-19B to facilitate the study of the intestinal transmissibility of this lambdoid phage.
Tn10d-bla, an 861-bp minitransposon which was constructed to
allow identification of phage-encoded exported proteins
(19), was used for this purpose. This small element
generates translational fusions between the mature portion of
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
In Vivo Transduction with Shiga Toxin
1-Encoding Phage
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
(10). Another lambdoid phage, designated 933W (isolated from
an E. coli O157:H7 strain from a patient with hemorrhagic
colitis), encodes Stx2 (15, 16). Although O157:H7 is the
most commonly isolated E. coli serotype associated with Stx
production and its related diseases in the United States, more than 30 other E. coli serotypes have been found to produce Stx and
to be associated with disease (2). Transient Stx production
has also been observed in other (non-E. coli) bacterial
species, including Enterobacter cloacae (18) and Citrobacter freundii (20) isolated from
patients with hemolytic-uremic syndrome. Dissemination of the lambdoid
phages which encode Stx1 and Stx2 is the likely mechanism accounting
for the spread of these toxins among diverse E. coli
serotypes and into other bacterial species. In the present study, we
sought to determine whether the Stx1-encoding phage H-19B can be
transmitted to another E. coli strain within the murine
intestine. An H-19B phage that was marked with an antibiotic resistance
marker was constructed to allow detection of intraintestinal H-19B
transmission by transduction.
-lactamase and the amino-terminal portion of the target gene product
(19). Plasmid pJR207 (19), which harbors Tn10d-bla, was introduced into E. coli C600 H-19B
in seven independent transformations, and ampicillin-resistant
(Apr) colonies were selected as described previously
(19). Approximately 10,000 Apr colonies were
then pooled, washed, and UV induced to produce seven independent H-19B
phage pool lysates. The streptomycin-resistant (Smr)
E. coli strain MC4100 (5) was then used as a
recipient strain for transduction with these lysates.
Ampicillin-resistant colonies were purified and tested for lysogeny by
cross-streaking. Lysogens were then used to produce new phage stocks
which were subsequently used to lysogenize MC4100. All lysogens were
resistant to ampicillin, thereby confirming the linkage of the
Apr gene to the H-19B phage genome.

View larger version (14K):
[in a new window]
FIG. 1.
Tn10d-bla insertions in the H-19B genome. The
3' end of the stxAB operon is encoded on a 2.8-kb
HindIII (H)-EcoRI (E) fragment
(10). The orientation of the stxAB operon along
with the locations of the Tn10d-bla insertions in H-19B-Ap1
and H-19B-Ap2 is shown.
TABLE 1.
Virion production by Apr gene-marked
H-19B lysogens
Intraintestinal transduction of phage H-19B. Oral administration of streptomycin to adult mice has been shown to facilitate the colonization of the murine large intestine with laboratory strains of E. coli (4). We used this model of intestinal colonization in streptomycin-treated mice to investigate whether MC4100 H-19B-Ap1 and MC4100 H-19B-Ap2 produce infectious virions within the intestine. Recovery of intestinally derived transductants of a recipient strain was used as a means to detect intraintestinal virion production.
Streptomycin (0.6 mg/ml) was added to water given to CD-1 mice for 48 h prior to the intragastric administration of MC4100 H-19B-Ap1 (Smr Apr LacZ
), the
phage donor strain. Stools collected from mice immediately prior to administration of the phage donor strain were found to have
no detectable Smr LacZ
CFU. Forty-five
minutes after the administration of the phage donor strain, the mice
were intragastrically inoculated with a differentially marked potential
phage recipient strain, AK16 (MC4100 srl::Tn5), which is identifiable as
Smr kanamycin-resistant (Knr)
LacZ
CFU. Approximately 1 × 109 cells
of the MC4100 H-19B-Ap1 lysogen and 2 × 109 cells of
AK16 were inoculated per mouse. Individual stool samples (pellets) were
collected on each of the four days following inoculation, homogenized
in 1 ml of Luria broth, and then plated on L agar containing
antibiotics to allow the determination of the number of donor CFU
(Smr Apr LacZ
), recipient CFU
(Smr Knr LacZ
), and transductant
CFU (Smr Knr Apr
LacZ
) in each pellet. Transductants (Apr
colonies of MC4100 srl::Tn5) were
recovered in stool samples on each of the four days following
inoculation. Twenty-four hours postinoculation, there was approximately
one transductant per 104 donor cells recovered in stool
(Table 2). Each of 10 randomly picked
Apr recipient colonies tested was found to produce StxB by
an enzyme-linked immunosorbent assay (1). In addition,
filtered supernatants from mitomycin C-induced cultures from each of
these AK16 Apr transductant colonies was capable of
transducing Apr to a new recipient strain. These results
indicate that H-19B-Ap1 phage transduction accounted for the intestinal
transmission of the Apr marker. There was a decrease in the
frequency of transductants per recipients during the 4-day period when
stools were tested (data not shown). At the end of this period the
animals were sacrificed, and the frequency of transductants in cecal
homogenates was found to be similar to the frequency of transductants
in the stool homogenates.
|
lysogens produce infectious virions
within the gastrointestinal tract (12) may suggest that new
toxinogenic V. cholerae serotypes, such as V. cholerae O139, may arise through phage-mediated transduction of
nontoxinogenic strains within the host gastrointestinal tract. Similar
phage conversion events may occur on other mucosal surfaces as well.
Pappenheimer and Murphy reported a case of corynephage conversion of a
nontoxinogenic Corynebacterium diphtheriae strain to
toxinogenicity that probably occurred within a woman's upper respiratory tract (17). It has been proposed that phage
conversion within a nonimmune host provides an efficient mechanism for
the rapid dissemination of phage-encoded virulence genes
(3). It is possible that specific mammalian host signals
induce bacterial gene transfer events, as has been described for the
plant pathogen Agrobacterium tumefaciens (13).
In the present study, the antibiotic resistance gene-marked H-19B
facilitated our ability to monitor intraintestinal phage production by
lysogens. The bla-marked H-19B phage will also facilitate the study of the bacterial host range for this virus and the study of
intestinal factors, such as diet, and therapeutic interventions, such
as antibiotics, that may influence the rate of intestinal H-19B
transduction. Our previous work indicates that SOS induction of
Stx-converting bacteriophages exerts a regulatory effect on Stx
production both by increasing the number of toxin gene copies and by
the increased expression of a phage-encoded regulatory molecule
(14). Future studies will address the question of whether intraintestinal Stx production and Stx-related disease require the in
vivo induction of Stx-converting bacteriophages from lysogens.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to the late H. Williams Smith for C600 H19B and to Carol Kumamoto for strain AK16. We thank Joe Newman for advice regarding the intestinal-colonization studies, Anne Kane and the NEMC GRASP Digestive Disease Center for preparing the microbiologic media for our studies, and A. Camilli for critical reading of the manuscript.
This work was supported by grants AI-42347 to M.K.W., AI-39067 to D.W.K.A., AI-16242 and HL-95007 to G.T.K., and P30DK-34928 for the NEMC GRASP Digestive Disease Center.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Geographic Medicine and Infectious Diseases, NEMC 041, 750 Washington St., Boston, MA 02111. Phone: (617) 636-7618. Fax: (617) 636-5292. E-mail: matthew.waldor{at}es.nemc.org.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Acheson, D. W. K.,
S. B. Calderwood,
S. A. Boyko,
L. L. Lincicome,
A. V. Kane,
A. Donohue-Rolfe, and G. T. Keusch.
1993.
Comparison of Shiga-like toxin I B-subunit expression and localization in Escherichia coli and Vibrio cholerae by using trc or iron-regulated promoter systems.
Infect. Immun.
61:1098-1104 |
| 2. | Acheson, D. W. K., and G. T. Keusch. 1996. Which Shiga toxin-producing types of E. coli are important? ASM News 62:302-306. |
| 3. | Bishai, W. R., and J. R. Murphy. 1988. Bacteriophage gene products that cause human disease, p. 683-724. In R. Calendar (ed.), The bacteriophages. Plenum Press, New York, N.Y. |
| 4. |
Burghoff, R. L.,
L. Pallesen,
K. A. Krogfelt,
J. V. Newman,
M. Richardson,
J. L. Bliss,
D. C. Laux, and P. S. Cohen.
1993.
Utilization of the mouse large intestine to select an Escherichia coli F-18 DNA sequence that enhances colonizing ability and stimulates synthesis of type 1 fimbriae.
Infect. Immun.
61:1293-1300 |
| 5. | Casadaban, M. J. 1976. Transposition and fusion of the lac genes to select promoters in Escherichia coli using bacteriophage lambda and Mu. J. Mol. Biol. 104:541-555[Medline]. |
| 6. | Cheetham, B. F., and M. E. Katz. 1995. A role for bacteriophages in the evolution and transfer of bacterial virulence determinants. Mol. Microbiol. 18:201-208[Medline]. |
| 7. |
Endo, Y., and K. Tsurugi.
1987.
RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes.
J. Biol. Chem.
262:8128-8130 |
| 8. | Griffin, P. M. 1995. Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli, p. 739-761. In M. J. Blaser, P. D. Smith, J. I. Ravdin, H. B. Greenberg, and R. L. Guerrant (ed.), Infections of the gastrointestinal tract. Raven Press, New York, N.Y. |
| 9. |
Huang, A.,
S. De Grandis,
J. Friesen,
M. Karmali,
M. Petric,
R. Congi, and J. L. Brunton.
1986.
Cloning and expression of the gene specifying Shiga-like toxin production in Escherichia coli H19.
J. Bacteriol.
166:375-379 |
| 10. |
Huang, A.,
J. Friesen, and J. L. Brunton.
1987.
Characterization of a bacteriophage that carries the genes for production of Shiga-like toxin 1 in Escherichia coli.
J. Bacteriol.
169:4308-4312 |
| 11. |
Jacewicz, M.,
H. Clausen,
E. Nudelman,
A. Donohue-Rolfe, and G. T. Keusch.
1986.
Pathogenesis of Shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
J. Exp. Med.
163:1391-1404 |
| 12. |
Lazar, S., and M. K. Waldor.
1998.
ToxR-independent expression of cholera toxin from the replicative form of CTX .
Infect. Immun.
66:394-397 |
| 13. | Mel, S., and J. J. Mekalanos. 1996. Modulation of horizontal gene transfer in pathogenic bacteria by in vivo signals. Cell 87:795-798[Medline]. |
| 14. | Mühldorfer, I., J. Hacker, G. T. Keusch, D. W. Acheson, H. Tschäpe, A. V. Kane, A. Ritter, T. Ölschläger, and A. Donohue-Rolfe. 1996. Regulation of the Shiga-like toxin II operon in Escherichia coli. Infect. Immun. 64:495-502[Abstract]. |
| 15. |
Newland, J. W.,
N. A. Strockbine,
A. D. O'Brien, and R. K. Holmes.
1985.
Cloning of shiga-like toxin structural genes from a toxin converting phage of Escherichia coli.
Science
230:179-181 |
| 16. |
O'Brien, A. D.,
J. W. Newland,
S. F. Miller,
R. K. Holmes,
H. Williams Smith, and S. B. Formal.
1984.
Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea.
Science
226:694-696 |
| 17. | Pappenheimer, A. M. J., and J. R. Murphy. 1983. Studies on the molecular epidemiology of diphtheria. Lancet ii:923-926. |
| 18. | Paton, A. W., and J. C. Paton. 1996. Enterobacter cloacae producing a Shiga-like toxin II-related cytotoxin associated with a case of hemolytic-uremic syndrome. J. Clin. Microbiol. 34:463-465[Abstract]. |
| 19. | Reidl, J., and J. J. Mekalanos. 1995. Characterization of Vibrio cholerae bacteriophage K139 and use of a novel mini-transposon to identify a phage-encoded virulence factor. Mol. Microbiol. 18:685-701[Medline]. |
| 20. | Tschape, H., R. Prager, W. Steckel, A. Fruth, E. Tietze, and G. Bohme. 1995. Verotoxinogenic Citrobacter freundii associated with severe gastroenteritis and cases of haemolytic uraemic syndrome in a nursery school: green butter as the infection source. Epidemiol. Infect. 114:441-450[Medline]. |
| 21. |
Williams Smith, H., and M. A. Linggood.
1971.
The transmissible nature of enterotoxin production in a human enteropathogenic strain of Escherichia coli.
J. Med. Microbiol.
4:301-305 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»